124 related articles for article (PubMed ID: 24004576)
1. [Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment].
Hadoux J; Morice P; Lhommé C; Duvillard P; Balleyguier C; Haie-Meder C; Gouy S; Uzan C; Mazeron R; Tazi Y; Leary A; Duffaud F; Pautier P
Bull Cancer; 2013 Sep; 100(9):903-15. PubMed ID: 24004576
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
[TBL] [Abstract][Full Text] [Related]
3. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Reprod Med; 2003 Feb; 48(2):95-100. PubMed ID: 12621792
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
Anticancer Res; 2003; 23(1B):729-32. PubMed ID: 12680175
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.
Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA
Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.
Loizzi V; Cormio G; Nestola D; Falagario M; Surgo A; Camporeale A; Putignano G; Selvaggi L
Oncology; 2011; 81(2):91-7. PubMed ID: 21968290
[TBL] [Abstract][Full Text] [Related]
7. Uterine leiomyosarcoma: diagnosis, treatment, and nursing management.
Smith T; McLaughlin P
Clin J Oncol Nurs; 2012 Jun; 16(3):267-72. PubMed ID: 22641318
[TBL] [Abstract][Full Text] [Related]
8. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
9. Leiomyosarcoma of uterus: a review of 14 cases.
Yu KJ; Ho DM; Ng HT; Chao KC; Kan YY
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Aug; 44(2):109-14. PubMed ID: 2819573
[TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant therapy in uterine leiomyosarcoma.
Ducie JA; Leitao MM
Expert Rev Anticancer Ther; 2016; 16(1):45-55. PubMed ID: 26558647
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant treatment on oncologic outcomes in patients with stage I leiomyosarcoma of the uterus.
Boyraz G; Başaran D; Salman MC; Özgül N; Yüce K
Turk J Med Sci; 2017 Jun; 47(3):841-846. PubMed ID: 28618731
[TBL] [Abstract][Full Text] [Related]
12. Uterine leiomyosarcoma: A review of the literature and update on management options.
Roberts ME; Aynardi JT; Chu CS
Gynecol Oncol; 2018 Dec; 151(3):562-572. PubMed ID: 30244960
[TBL] [Abstract][Full Text] [Related]
13. c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment.
Raspollini MR; Amunni G; Villanucci A; Pinzani P; Simi L; Paglierani M; Taddei GL
Clin Cancer Res; 2004 May; 10(10):3500-3. PubMed ID: 15161707
[TBL] [Abstract][Full Text] [Related]
14. Trends in the treatment of uterine leiomyosarcoma in the Medicare population.
Foley OW; Rauh-Hain JA; Clemmer J; Clark RM; Hall T; Diver EJ; Schorge JO; del Carmen MG
Int J Gynecol Cancer; 2015 Mar; 25(3):453-8. PubMed ID: 25628107
[TBL] [Abstract][Full Text] [Related]
15. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
16. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases.
Mayerhofer K; Obermair A; Windbichler G; Petru E; Kaider A; Hefler L; Czerwenka K; Leodolter S; Kainz C
Gynecol Oncol; 1999 Aug; 74(2):196-201. PubMed ID: 10419731
[TBL] [Abstract][Full Text] [Related]
17. Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.
Cui RR; Wright JD; Hou JY
BJOG; 2017 Jun; 124(7):1028-1037. PubMed ID: 28128524
[TBL] [Abstract][Full Text] [Related]
18. Treatment of uterine leiomyosarcoma.
Berchuck A; Rubin SC; Hoskins WJ; Saigo PE; Pierce VK; Lewis JL
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):845-50. PubMed ID: 2453004
[TBL] [Abstract][Full Text] [Related]
19. [Histopathological, clinical and prognostic aspects of smooth-muscle tumors of the uterus (cellular myoma, leiomyosarcoma, endometrial stromal sarcoma)].
De Giacomo G; Palla G; Paparatti L; Villani L; Moneta E
Minerva Ginecol; 1988 Feb; 40(2):73-81. PubMed ID: 3399122
[No Abstract] [Full Text] [Related]
20. Options for Adjuvant Therapy for Uterine Leiomyosarcoma.
Friedman CF; Hensley ML
Curr Treat Options Oncol; 2018 Feb; 19(2):7. PubMed ID: 29417238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]